Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

65/99

BSE: 524669 | NSE: HESTERBIO

Watchlist

NSE BSE

2264.90

11-Sep-2026

Open
High
Low
Previous Close

2275
2298.9
2238.3
2279.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5276
11972952.7
2683.6
1239.3

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,948.03
14.31
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,129.75
0.48%
4.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.45
7.19
2.98

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.16
6.43
9.03

PAT CAGR (%)

10 Years
5 Years
3 Years

8.98
7.19
43.34

P:E (Median)

8 Years
5 Years
3 Years

49.47
50.99
49.80

P:BV (Average)

8 Years
5 Years
3 Years

6.37
5.80
5.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

24.73
26.03
25.51

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 72.66 63.49 14.44% 93.71 76.67 22.23% 70.35 62.83 11.97% 64.58 73.50 -12.14%
Expenses 48.31 51.08 -5.42% 62.25 62.97 -1.14% 53.64 53.81 -0.32% 52.70 58.77 -10.33%
EBITDA 24.35 12.41 96.21% 31.46 13.70 129.64% 16.72 9.01 85.57% 11.88 14.73 -19.35%
EBIDTM 33.51% 19.55% 33.58% 17.87% 23.76% 14.35% 18.40% 20.04%
Other Income 1.68 0.95 76.84% 4.18 1.06 294.34% 1.03 1.30 -20.77% 1.48 1.35 9.63%
Interest 1.36 0.91 49.45% 4.09 1.25 227.20% 0.90 1.59 -43.40% 1.27 1.40 -9.29%
Depreciation 4.92 2.16 127.78% 3.68 2.03 81.28% 2.21 2.24 -1.34% 2.20 2.19 0.46%
PBT 19.75 10.29 91.93% 34.87 11.48 203.75% 14.64 6.49 125.58% 9.88 12.48 -20.83%
Tax 5.04 2.45 105.71% 8.49 1.85 358.92% 3.97 2.05 93.66% 2.67 3.15 -15.24%
PAT 14.71 7.84 87.63% 26.38 9.63 173.94% 10.67 4.44 140.32% 7.21 9.34 -22.81%
PATM 20.25% 12.35% 28.15% 12.57% 15.16% 7.07% 11.16% 12.70%
EPS 17.31 9.22 87.74% 31.04 11.34 173.72% 12.55 5.22 140.42% 8.48 10.98 -22.77%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 77.24 84.10 -8.16% 100.11 81.92 22.20% 77.41 63.22 22.45% 70.97 83.69 -15.20%
Expenses 54.47 61.29 -11.13% 65.78 62.74 4.85% 59.62 58.16 2.51% 59.25 64.53 -8.18%
EBITDA 22.78 22.81 -0.13% 34.33 19.18 78.99% 17.79 5.06 251.58% 11.72 19.16 -38.83%
EBIDTM 29.49% 27.13% 34.29% 23.41% 22.98% 8.01% 16.51% 22.89%
Other Income 1.64 2.32 -29.31% -3.03 -6.95 - 0.67 7.81 -91.42% 9.73 1.84 428.80%
Interest 3.08 1.81 70.17% 5.10 5.62 -9.25% 1.82 -3.81 - 2.21 5.89 -62.48%
Depreciation 7.04 4.18 68.42% 5.91 4.18 41.39% 4.43 4.29 3.26% 4.35 4.20 3.57%
PBT 99.65 19.14 420.64% 23.23 2.44 852.05% 12.21 12.39 -1.45% 14.88 10.91 36.39%
Tax 4.95 2.89 71.28% 8.54 2.20 288.18% 4.21 1.96 114.80% 2.71 3.48 -22.13%
PAT 94.70 16.25 482.77% 14.69 0.23 6,286.96% 8.00 10.43 -23.30% 12.18 7.44 63.71%
PATM 122.59% 19.32% 14.67% 0.28% 10.33% 16.50% 17.16% 8.88%
EPS 114.00 19.33 489.76% 18.79 1.52 1,136.18% 10.30 13.71 -24.87% 16.98 9.64 76.14%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 301.30 292.14 286.47 285.15 254.00 219.35 208.48 169.43 171.19 134.79 123.28 Net Sales Growth 8.97% 1.98% 0.46% 12.26% 15.80% 5.21% 23.05% -1.03% 27.00% 9.34% Cost Of Goods Sold 78.44 81.97 93.65 99.64 79.88 63.84 53.39 29.24 29.21 23.31 29.89 Gross Profit 222.86 210.17 192.81 185.51 174.12 155.51 155.08 140.19 141.97 111.47 93.39 GP Margin 73.97% 71.94% 67.31% 65.06% 68.55% 70.90% 74.39% 82.74% 82.93% 82.70% 75.75% Total Expenditure 216.90 224.39 235.52 238.30 199.32 158.78 136.48 116.70 103.42 85.19 82.21 Power & Fuel Cost - 9.20 10.12 12.34 9.95 8.74 6.93 7.29 7.08 5.84 5.31 % Of Sales - 3.15% 3.53% 4.33% 3.92% 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% Employee Cost - 53.17 54.76 56.72 47.92 39.12 33.45 37.16 26.74 22.29 18.32 % Of Sales - 18.20% 19.12% 19.89% 18.87% 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% Manufacturing Exp. - 15.22 15.62 15.20 10.54 10.17 10.79 11.31 10.95 9.24 6.97 % Of Sales - 5.21% 5.45% 5.33% 4.15% 4.64% 5.18% 6.68% 6.40% 6.86% 5.65% General & Admin Exp. - 25.43 26.01 24.92 21.60 14.50 13.24 16.34 11.77 12.92 11.35 % Of Sales - 8.70% 9.08% 8.74% 8.50% 6.61% 6.35% 9.64% 6.88% 9.59% 9.21% Selling & Distn. Exp. - 24.46 26.89 24.63 24.68 17.16 13.68 11.42 16.02 9.09 8.15 % Of Sales - 8.37% 9.39% 8.64% 9.72% 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% Miscellaneous Exp. - 14.93 8.46 4.86 4.76 5.26 5.00 3.95 1.65 2.50 8.15 % Of Sales - 5.11% 2.95% 1.70% 1.87% 2.40% 2.40% 2.33% 0.96% 1.85% 1.80% EBITDA 84.41 67.75 50.95 46.85 54.68 60.57 72.00 52.73 67.77 49.60 41.07 EBITDA Margin 28.02% 23.19% 17.79% 16.43% 21.53% 27.61% 34.54% 31.12% 39.59% 36.80% 33.31% Other Income 8.37 12.36 4.76 4.75 5.53 4.66 1.65 2.93 3.10 1.88 0.73 Interest 7.62 7.17 5.37 5.09 6.50 2.47 3.95 5.03 3.54 2.32 3.21 Depreciation 13.01 10.25 8.58 9.78 9.79 9.50 9.63 9.38 7.57 5.45 5.51 PBT 79.14 62.69 41.76 36.73 43.92 53.26 60.06 41.23 59.75 43.71 33.09 Tax 20.17 17.58 9.92 9.57 11.58 13.74 14.88 10.01 15.90 13.15 8.15 Tax Rate 25.49% 25.23% 23.75% 26.05% 26.37% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% PAT 58.97 52.10 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 PAT before Minority Interest 58.97 52.10 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.57% 17.83% 11.11% 9.52% 12.73% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% PAT Growth 88.70% 63.63% 17.23% -16.02% -18.17% -0.95% 27.80% -28.80% 43.49% 22.53% EPS 69.38 61.29 37.46 31.95 38.05 46.49 46.94 36.73 51.59 35.95 29.34

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 325.73 332.60 311.10 304.55 266.09 235.01 214.33 183.27 178.07 135.94 123.11 Net Sales Growth 4.09% 6.91% 2.15% 14.45% 13.22% 9.65% 16.95% 2.92% 30.99% 10.42% Cost Of Goods Sold 76.57 81.96 88.33 95.88 77.49 64.85 50.23 27.98 28.47 23.31 28.45 Gross Profit 249.16 250.64 222.78 208.67 188.60 170.15 164.11 155.29 149.60 112.63 94.65 GP Margin 76.49% 75.36% 71.61% 68.52% 70.88% 72.40% 76.57% 84.73% 84.01% 82.85% 76.88% Total Expenditure 239.12 250.66 250.05 251.38 215.69 175.02 145.67 127.87 110.03 88.68 82.09 Power & Fuel Cost - 11.57 13.98 15.30 12.74 10.28 7.57 8.13 7.83 6.37 5.59 % Of Sales - 3.48% 4.49% 5.02% 4.79% 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% Employee Cost - 62.67 62.42 64.13 56.02 45.33 38.92 40.65 28.93 23.24 18.32 % Of Sales - 18.84% 20.06% 21.06% 21.05% 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% Manufacturing Exp. - 17.99 18.05 17.13 12.67 11.51 11.60 11.98 11.34 9.45 7.06 % Of Sales - 5.41% 5.80% 5.62% 4.76% 4.90% 5.41% 6.54% 6.37% 6.95% 5.73% General & Admin Exp. - 29.54 29.64 27.17 24.89 19.20 15.29 13.47 13.72 13.81 11.47 % Of Sales - 8.88% 9.53% 8.92% 9.35% 8.17% 7.13% 7.35% 7.70% 10.16% 9.32% Selling & Distn. Exp. - 27.17 28.28 25.60 26.34 17.31 14.73 18.97 16.77 9.11 8.15 % Of Sales - 8.17% 9.09% 8.41% 9.90% 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% Miscellaneous Exp. - 19.77 9.36 6.18 5.54 6.53 7.34 6.69 2.98 3.40 8.15 % Of Sales - 5.94% 3.01% 2.03% 2.08% 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% EBITDA 86.62 81.94 61.05 53.17 50.40 59.99 68.66 55.40 68.04 47.26 41.02 EBITDA Margin 26.59% 24.64% 19.62% 17.46% 18.94% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% Other Income 9.01 14.41 3.92 11.13 15.36 13.74 4.68 6.37 7.21 2.55 0.42 Interest 12.21 10.93 12.70 19.77 9.32 4.06 6.60 7.37 6.63 4.04 3.50 Depreciation 21.73 18.88 16.80 17.17 20.70 16.58 13.31 13.07 11.76 9.66 7.00 PBT 149.97 66.53 35.47 27.34 35.74 53.08 53.42 41.33 56.86 36.12 30.93 Tax 20.41 18.35 10.74 10.79 12.12 14.02 15.40 10.32 16.16 13.05 8.15 Tax Rate 13.61% 26.41% 30.28% 39.47% 33.91% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% PAT 129.57 55.63 27.49 18.89 26.63 39.32 34.43 29.17 41.56 25.62 23.55 PAT before Minority Interest 128.83 57.48 28.83 21.17 28.04 39.48 34.70 31.00 40.69 23.07 22.79 Minority Interest -0.74 -1.85 -1.34 -2.28 -1.41 -0.16 -0.27 -1.83 0.87 2.55 0.76 PAT Margin 39.78% 16.73% 8.84% 6.20% 10.01% 16.73% 16.06% 15.92% 23.34% 18.85% 19.13% PAT Growth 277.21% 102.36% 45.53% -29.06% -32.27% 14.20% 18.03% -29.81% 62.22% 8.79% EPS 152.44 65.45 32.34 22.22 31.33 46.26 40.51 34.32 48.89 30.14 27.71

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 385.18 339.09 312.71 292.38 268.43 237.58 203.08 179.44 146.08 122.09 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 376.68 330.58 304.20 283.88 259.93 229.07 194.57 170.93 137.57 113.58 Non-Current Liabilities 80.25 110.21 139.11 116.96 81.17 9.79 15.89 21.51 21.98 22.36 Secured Loans 21.68 51.31 79.07 83.40 73.25 2.68 7.45 11.37 14.61 18.66 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.34 2.38 2.26 1.72 1.08 0.00 0.00 0.00 0.00 0.00 Current Liabilities 91.92 96.70 97.72 136.47 74.84 34.65 58.22 39.30 42.43 33.99 Trade Payables 20.56 32.53 29.68 28.71 11.03 14.03 13.61 8.05 7.85 7.47 Other Current Liabilities 40.79 30.86 35.58 46.59 29.34 15.11 12.37 10.05 9.33 7.82 Short Term Borrowings 24.30 28.64 29.79 57.34 33.29 1.71 31.80 20.94 24.19 17.51 Short Term Provisions 6.26 4.67 2.67 3.83 1.18 3.81 0.44 0.26 1.06 1.18 Total Liabilities 557.35 546.00 549.54 545.81 424.44 282.02 277.19 240.25 210.49 178.44 Net Block 288.01 105.46 103.46 108.22 84.31 86.69 96.76 100.81 66.74 60.85 Gross Block 401.86 212.38 203.62 199.00 171.17 164.64 166.61 161.97 120.89 109.55 Accumulated Depreciation 113.85 106.92 100.16 90.78 86.86 77.95 69.85 61.02 54.15 48.70 Non Current Assets 367.58 360.76 345.13 329.77 257.97 142.41 154.01 140.84 121.36 103.63 Capital Work in Progress 9.33 182.70 171.40 148.61 81.91 3.72 0.87 0.42 30.47 21.29 Non Current Investment 64.28 64.69 64.69 64.69 64.69 43.88 40.67 28.22 14.48 8.60 Long Term Loans & Adv. 5.47 6.30 4.85 6.83 24.20 5.32 11.83 9.81 9.59 12.41 Other Non Current Assets 0.49 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 Current Assets 189.76 185.24 204.41 216.05 166.47 139.61 123.18 99.40 89.13 74.81 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 59.98 58.51 68.53 79.22 70.73 57.01 60.43 48.50 38.70 33.07 Sundry Debtors 92.04 80.59 85.78 82.36 56.92 45.55 44.76 32.67 31.94 26.71 Cash & Bank 4.56 2.18 4.96 5.96 1.98 1.24 5.19 2.49 11.95 11.48 Other Current Assets 33.18 7.16 5.36 5.45 36.84 35.80 12.80 15.74 6.54 3.56 Short Term Loans & Adv. 26.79 36.80 39.78 43.06 34.01 29.50 11.84 12.95 5.69 3.30 Net Current Assets 97.85 88.53 106.69 79.58 91.64 104.96 64.96 60.10 46.70 40.82 Total Assets 557.34 546.00 549.54 545.82 424.44 282.02 277.19 240.24 210.49 178.44

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 360.24 314.25 291.79 279.73 259.99 228.31 201.07 177.46 140.63 121.95 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 351.73 305.75 283.29 271.22 251.48 219.80 192.56 168.95 132.13 113.44 Non-Current Liabilities 157.67 201.54 254.00 232.72 197.87 113.72 96.64 69.64 44.41 48.32 Secured Loans 89.96 133.37 182.09 184.85 164.54 82.84 76.48 58.35 36.54 44.62 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.34 2.75 2.53 1.93 1.27 0.00 0.00 0.00 0.00 0.00 Current Liabilities 152.48 125.18 105.47 148.70 96.90 61.37 83.46 48.66 54.63 38.01 Trade Payables 24.68 29.42 25.86 29.98 18.02 28.09 20.02 8.75 7.90 7.47 Other Current Liabilities 96.98 61.14 45.05 55.96 42.81 22.52 30.44 17.15 20.26 11.04 Short Term Borrowings 24.29 29.58 31.35 58.86 34.84 3.28 32.54 22.50 25.41 18.32 Short Term Provisions 6.53 5.05 3.22 3.90 1.22 7.48 0.46 0.26 1.07 1.18 Total Liabilities 677.94 653.37 662.34 669.97 562.17 411.05 386.59 299.46 244.04 212.88 Net Block 411.46 233.31 240.11 259.37 237.17 132.76 142.54 144.82 110.22 102.62 Gross Block 585.32 390.00 382.04 385.80 348.16 228.12 226.04 215.94 170.22 152.95 Accumulated Depreciation 173.87 156.69 141.93 126.43 110.99 95.36 83.50 70.98 60.00 50.33 Non Current Assets 469.38 458.21 447.73 442.37 367.40 249.54 227.29 157.80 145.59 132.91 Capital Work in Progress 9.33 182.70 171.40 148.61 81.91 109.17 74.15 7.05 31.81 21.29 Non Current Investment 42.58 34.05 29.93 25.30 21.24 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.53 6.54 5.55 7.67 24.22 4.82 6.74 4.34 3.48 8.52 Other Non Current Assets 0.49 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 Current Assets 208.56 195.17 214.62 227.59 194.76 161.50 159.31 141.66 98.45 79.97 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 72.53 70.38 75.58 84.81 75.38 62.22 63.97 50.79 39.76 33.41 Sundry Debtors 95.36 73.18 78.64 79.63 55.28 49.21 58.44 32.87 32.29 26.53 Cash & Bank 6.54 7.22 15.30 14.82 25.20 21.27 23.53 41.05 13.39 11.48 Other Current Assets 34.14 7.51 5.81 6.02 38.90 28.80 13.37 16.95 13.01 8.54 Short Term Loans & Adv. 27.13 36.88 39.27 42.31 33.70 26.24 8.19 11.32 8.95 5.06 Net Current Assets 56.08 69.99 109.14 78.90 97.87 100.14 75.84 92.99 43.82 41.95 Total Assets 677.94 653.38 662.35 669.96 562.16 411.04 386.60 299.46 244.04 212.88

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 50.92 63.97 42.86 33.36 15.90 41.10 25.82 36.19 32.28 27.55 PBT 69.68 41.76 36.73 43.92 53.26 54.78 41.23 59.75 43.71 33.09 Adjustment 12.23 15.82 13.32 14.55 11.70 19.61 12.25 8.50 7.34 8.74 Changes in Working Capital -17.50 16.31 3.84 -17.05 -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 Cash after chg. in Working capital 64.41 73.89 53.89 41.43 32.34 54.59 37.17 51.78 41.67 34.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.49 -9.92 -11.03 -8.06 -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2.36 -19.04 -20.59 -71.96 -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 Net Fixed Assets -16.11 -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 Net Investments 0.41 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 Others 13.34 1.02 6.82 22.57 -5.05 0.37 -3.79 0.07 0.08 -0.26 Cash from Financing Activity -48.31 -46.35 -24.12 41.38 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 Net Cash Inflow / Outflow 0.25 -1.42 -1.85 2.77 0.28 -3.95 3.10 -8.80 -0.28 6.46 Opening Cash & Equivalents 0.55 1.97 3.81 1.53 1.24 5.19 2.09 10.89 11.17 4.71 Closing Cash & Equivalent 0.79 0.55 1.97 4.30 1.53 1.24 5.19 2.09 10.89 11.17

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 64.14 64.51 48.18 23.60 8.71 58.05 36.77 46.71 38.02 34.80 PBT 75.84 39.57 31.95 40.15 53.50 50.10 41.33 56.86 36.12 30.93 Adjustment 33.57 26.47 24.22 12.39 11.10 20.34 20.13 17.92 13.63 10.86 Changes in Working Capital -31.14 9.95 3.67 -20.84 -38.78 1.54 -13.75 -12.26 -2.31 0.11 Cash after chg. in Working capital 78.27 75.98 59.85 31.70 25.82 71.99 47.71 62.52 47.44 41.90 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.12 -11.47 -11.67 -8.11 -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 Cash From Investing Activity -2.87 -19.00 -22.61 -77.00 -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 Net Fixed Assets -16.11 -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 Net Investments 0.41 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 Others 12.83 1.06 4.80 17.53 -11.06 -34.28 -56.93 3.04 0.57 -14.96 Cash from Financing Activity -48.79 -51.72 -26.09 41.76 111.54 -18.22 18.74 2.65 -11.08 1.83 Net Cash Inflow / Outflow 12.48 -6.21 -0.52 -11.64 3.66 1.46 -18.96 27.63 1.12 6.45 Opening Cash & Equivalents 5.59 12.31 12.67 24.75 21.27 23.53 40.65 12.33 11.18 4.73 Closing Cash & Equivalent 2.77 5.59 12.31 13.16 24.75 21.27 23.53 40.65 12.33 11.18

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 452.78 398.60 367.59 343.70 315.54 279.28 238.72 210.93 171.72 143.52 ROA 9.44% 5.81% 4.96% 6.67% 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% ROE 14.39% 9.77% 8.98% 11.53% 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% ROCE 17.02% 10.59% 9.26% 11.91% 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% Fixed Asset Turnover 0.95 1.38 1.42 1.38 1.32 1.26 1.03 1.21 1.17 1.17 Receivable days 107.78 105.93 107.52 99.32 84.52 79.06 83.41 68.88 79.13 76.95 Inventory Days 73.98 80.88 94.48 106.93 105.37 102.81 117.33 92.96 96.84 96.91 Payable days 118.21 121.23 106.95 90.79 71.61 94.44 36.28 28.05 36.46 33.72 Cash Conversion Cycle 63.54 65.58 95.05 115.46 118.28 87.43 164.47 133.79 139.51 140.15 Total Debt/Equity 0.19 0.31 0.43 0.56 0.45 0.07 0.24 0.21 0.29 0.32 Interest Cover 10.72 8.78 8.21 7.76 22.58 14.88 9.19 17.87 19.88 11.31

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 423.46 369.41 343.00 328.82 305.61 268.38 236.36 208.61 165.32 143.35 ROA 8.64% 4.38% 3.18% 4.55% 8.11% 8.70% 9.04% 14.97% 10.10% 11.43% ROE 17.05% 9.51% 7.41% 10.39% 16.17% 16.16% 16.38% 25.59% 17.57% 20.38% ROCE 16.21% 9.93% 9.59% 9.60% 14.12% 17.33% 16.53% 26.64% 20.20% 19.75% Fixed Asset Turnover 0.68 0.81 0.79 0.73 0.82 0.95 0.83 0.92 0.84 0.96 Receivable days 92.43 89.02 94.77 91.87 80.50 91.49 90.92 66.77 78.70 76.80 Inventory Days 78.37 85.58 96.04 109.08 106.00 107.25 114.27 92.80 97.89 97.55 Payable days 120.46 114.21 106.28 113.04 129.73 174.82 42.10 27.25 33.70 33.48 Cash Conversion Cycle 50.33 60.38 84.54 87.91 56.77 23.92 163.09 132.33 142.89 140.87 Total Debt/Equity 0.52 0.66 0.82 0.96 0.86 0.46 0.60 0.51 0.49 0.54 Interest Cover 7.94 4.12 2.62 5.31 14.16 8.59 6.61 9.57 9.95 9.84

Top Investors:

kuntal hasmukhlal shah

darshna dinesh kapadia

sandeep shantilal gala

manish jain (huf)

manish prataprai gandhi

jagrut prataprai gandhi

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hester Biosciences - Quarterly Results
31st Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback